Global Botanical and Plant-Derived Drugs Market 2023-2027

Description

List of Tables

The botanical and plant-derived drugs market is forecasted to grow by USD 22.61 bn during 2022-2027, accelerating at a CAGR of 9.23% during the forecast period. The report on the botanical and plant-derived drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in government initiatives to use plant-derived drugs, limitations associated with conventional drugs, and growing demand for effective treatment of chronic disorders.

Technavio's botanical and plant-derived drugs market is segmented as below:

By Product

Plant-derived drugs
Botanical drugs

By Application

Infectious diseases
Central nervous system
Cardiovascular diseases
Respiratory diseases

By Geographical Landscape

Asia
Europe
North America
Rest of World (ROW)

This study identifies the transformation of the regulatory landscape in the US as one of the prime reasons driving the botanical and plant-derived drugs market growth during the next few years. Also, growing focus on the development of drugs for new indications and emergence of new entrants will lead to sizable demand in the market.

The report on the botanical and plant-derived drugs market covers the following areas:

Botanical and plant-derived drugs market sizing
Botanical and plant-derived drugs market forecast
Botanical and plant-derived drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading botanical and plant-derived drugs market vendors that include Bausch Health Co. Inc., Bayer AG, Devonian Health Group Inc., Dr. Willmar Schwabe GmbH and Co. KG, F. Hoffmann La Roche Ltd., Hetero Labs Ltd., Jaguar Health Inc., Jazz Pharmaceuticals Plc, Johnson and Johnson Services Inc., Medigene AG, Merck KGaA, Mitsubishi Chemical Group Corp., Novartis AG, Pierre Fabre SA, Protalix Biotherapeutics Inc., Sanofi, and Sun Pharmaceutical Industries Ltd.. Also, the botanical and plant-derived drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR45751

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global botanical and plant-derived drugs market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global botanical and plant-derived drugs market 2017 - 2021 ($ billion)
4.2 Product Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
4.3 Application Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ billion)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product

6.1 Market segments
Exhibit 30: Chart on Product - Market share 2022-2027 (%)
Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Plant-derived drugs - Market size and forecast 2022-2027
Exhibit 34: Chart on Plant-derived drugs - Market size and forecast 2022-2027 ($ billion)
Exhibit 35: Data Table on Plant-derived drugs - Market size and forecast 2022-2027 ($ billion)
Exhibit 36: Chart on Plant-derived drugs - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Plant-derived drugs - Year-over-year growth 2022-2027 (%)
6.4 Botanical drugs - Market size and forecast 2022-2027
Exhibit 38: Chart on Botanical drugs - Market size and forecast 2022-2027 ($ billion)
Exhibit 39: Data Table on Botanical drugs - Market size and forecast 2022-2027 ($ billion)
Exhibit 40: Chart on Botanical drugs - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Botanical drugs - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Product
Exhibit 42: Market opportunity by Product ($ billion)
Exhibit 43: Data Table on Market opportunity by Product ($ billion)

7 Market Segmentation by Application

7.1 Market segments
Exhibit 44: Chart on Application - Market share 2022-2027 (%)
Exhibit 45: Data Table on Application - Market share 2022-2027 (%)
7.2 Comparison by Application
Exhibit 46: Chart on Comparison by Application
Exhibit 47: Data Table on Comparison by Application
7.3 Infectious diseases - Market size and forecast 2022-2027
Exhibit 48: Chart on Infectious diseases - Market size and forecast 2022-2027 ($ billion)
Exhibit 49: Data Table on Infectious diseases - Market size and forecast 2022-2027 ($ billion)
Exhibit 50: Chart on Infectious diseases - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Infectious diseases - Year-over-year growth 2022-2027 (%)
7.4 Central nervous system - Market size and forecast 2022-2027
Exhibit 52: Chart on Central nervous system - Market size and forecast 2022-2027 ($ billion)
Exhibit 53: Data Table on Central nervous system - Market size and forecast 2022-2027 ($ billion)
Exhibit 54: Chart on Central nervous system - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Central nervous system - Year-over-year growth 2022-2027 (%)
7.5 Cardiovascular diseases - Market size and forecast 2022-2027
Exhibit 56: Chart on Cardiovascular diseases - Market size and forecast 2022-2027 ($ billion)
Exhibit 57: Data Table on Cardiovascular diseases - Market size and forecast 2022-2027 ($ billion)
Exhibit 58: Chart on Cardiovascular diseases - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Cardiovascular diseases - Year-over-year growth 2022-2027 (%)
7.6 Respiratory diseases - Market size and forecast 2022-2027
Exhibit 60: Chart on Respiratory diseases - Market size and forecast 2022-2027 ($ billion)
Exhibit 61: Data Table on Respiratory diseases - Market size and forecast 2022-2027 ($ billion)
Exhibit 62: Chart on Respiratory diseases - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Respiratory diseases - Year-over-year growth 2022-2027 (%)
7.7 Market opportunity by Application
Exhibit 64: Market opportunity by Application ($ billion)
Exhibit 65: Data Table on Market opportunity by Application ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 Asia - Market size and forecast 2022-2027
Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 North America - Market size and forecast 2022-2027
Exhibit 79: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 80: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 81: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Japan - Market size and forecast 2022-2027
Exhibit 91: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibit 92: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibit 93: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.9 China - Market size and forecast 2022-2027
Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
9.10 UK - Market size and forecast 2022-2027
Exhibit 99: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 100: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 101: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.11 Germany - Market size and forecast 2022-2027
Exhibit 103: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 104: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 105: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ billion)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 Bausch Health Co. Inc.
Exhibit 115: Bausch Health Co. Inc. - Overview
Exhibit 116: Bausch Health Co. Inc. - Business segments
Exhibit 117: Bausch Health Co. Inc. - Key news
Exhibit 118: Bausch Health Co. Inc. - Key offerings
Exhibit 119: Bausch Health Co. Inc. - Segment focus
12.4 Bayer AG
Exhibit 120: Bayer AG - Overview
Exhibit 121: Bayer AG - Business segments
Exhibit 122: Bayer AG - Key news
Exhibit 123: Bayer AG - Key offerings
Exhibit 124: Bayer AG - Segment focus
12.5 Dr. Willmar Schwabe GmbH and Co. KG
Exhibit 125: Dr. Willmar Schwabe GmbH and Co. KG - Overview
Exhibit 126: Dr. Willmar Schwabe GmbH and Co. KG - Product / Service
Exhibit 127: Dr. Willmar Schwabe GmbH and Co. KG - Key offerings
12.6 F. Hoffmann La Roche Ltd.
Exhibit 128: F. Hoffmann La Roche Ltd. - Overview
Exhibit 129: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 130: F. Hoffmann La Roche Ltd. - Key news
Exhibit 131: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 132: F. Hoffmann La Roche Ltd. - Segment focus
12.7 Hetero Labs Ltd.
Exhibit 133: Hetero Labs Ltd. - Overview
Exhibit 134: Hetero Labs Ltd. - Product / Service
Exhibit 135: Hetero Labs Ltd. - Key offerings
12.8 Jaguar Health Inc.
Exhibit 136: Jaguar Health Inc. - Overview
Exhibit 137: Jaguar Health Inc. - Business segments
Exhibit 138: Jaguar Health Inc. - Key offerings
Exhibit 139: Jaguar Health Inc. - Segment focus
12.9 Jazz Pharmaceuticals Plc
Exhibit 140: Jazz Pharmaceuticals Plc - Overview
Exhibit 141: Jazz Pharmaceuticals Plc - Product / Service
Exhibit 142: Jazz Pharmaceuticals Plc - Key news
Exhibit 143: Jazz Pharmaceuticals Plc - Key offerings
12.10 Johnson and Johnson Services Inc.
Exhibit 144: Johnson and Johnson Services Inc. - Overview
Exhibit 145: Johnson and Johnson Services Inc. - Business segments
Exhibit 146: Johnson and Johnson Services Inc. - Key news
Exhibit 147: Johnson and Johnson Services Inc. - Key offerings
Exhibit 148: Johnson and Johnson Services Inc. - Segment focus
12.11 Merck KGaA
Exhibit 149: Merck KGaA - Overview
Exhibit 150: Merck KGaA - Business segments
Exhibit 151: Merck KGaA - Key news
Exhibit 152: Merck KGaA - Key offerings
Exhibit 153: Merck KGaA - Segment focus
12.12 Mitsubishi Chemical Group Corp.
Exhibit 154: Mitsubishi Chemical Group Corp. - Overview
Exhibit 155: Mitsubishi Chemical Group Corp. - Business segments
Exhibit 156: Mitsubishi Chemical Group Corp. - Key offerings
Exhibit 157: Mitsubishi Chemical Group Corp. - Segment focus
12.13 Novartis AG
Exhibit 158: Novartis AG - Overview
Exhibit 159: Novartis AG - Business segments
Exhibit 160: Novartis AG - Key offerings
Exhibit 161: Novartis AG - Segment focus
12.14 Pierre Fabre SA
Exhibit 162: Pierre Fabre SA - Overview
Exhibit 163: Pierre Fabre SA - Business segments
Exhibit 164: Pierre Fabre SA - Key offerings
Exhibit 165: Pierre Fabre SA - Segment focus
12.15 Protalix Biotherapeutics Inc.
Exhibit 166: Protalix Biotherapeutics Inc. - Overview
Exhibit 167: Protalix Biotherapeutics Inc. - Product / Service
Exhibit 168: Protalix Biotherapeutics Inc. - Key offerings
12.16 Sanofi
Exhibit 169: Sanofi - Overview
Exhibit 170: Sanofi - Business segments
Exhibit 171: Sanofi - Key news
Exhibit 172: Sanofi - Key offerings
Exhibit 173: Sanofi - Segment focus
12.17 Sun Pharmaceutical Industries Ltd.
Exhibit 174: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 175: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 176: Sun Pharmaceutical Industries Ltd. - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 177: Inclusions checklist
Exhibit 178: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 179: Currency conversion rates for US$
13.4 Research methodology
Exhibit 180: Research methodology
Exhibit 181: Validation techniques employed for market sizing
Exhibit 182: Information sources
13.5 List of abbreviations
Exhibit 183: List of abbreviations